Grünenthal Report 2025/2026

At Grünenthal, our teams are driving progress toward our vision of a World Free of Pain. Guided by a clear strategy, we have transformed the company to position it for long-term success. Since 2017, this transformation has delivered sustainable growth, a diversified portfolio and a strong innovation pipeline to improve patient care, while fostering a culture that attracts international talent.

Grünenthal is a global leader in pain management and related diseases.

We have a long track record of bringing innovative treatments to patients worldwide.

As a fully integrated pharmaceutical company, we cover the entire value chain – from drug research and development to commercialisation of portfolios with growth products and established medicines.

We operate in accordance with the highest ethical and regulatory standards, and we focus our efforts on our vision of a World Free of Pain.